Lithium aspartate fails to improve long COVID symptoms, but higher doses may hold promise
Lithium aspartate at 10-15 mg/d is ineffective for treating cognitive dysfunction and fatigue in long COVID, but higher doses may offer potential benefits based...
Initial trials of low-dose lithium failed to improve long COVID symptoms, but new findings suggest higher doses could offer hope for patients suffering from fat...
Read More
Other Stories in Health
- Keynote Selena Gomez spotlights prioritizing mental health during Academy Women's Luncheon
- UVM scientists discover new mechanism for blood flow regulation in the brain
- More cancer patients die here than in US, South Korea, Japan: Paper
- 'Yellowstone' Season 5 Episode 13 Recap: What Happened?
- Route to Christmas: Day 9 2024
- Depression genes amplify women's heart disease risk
- Measles & Rubella Weekly Monitoring Report – Week 20: May 12 to May 18, 2024
- 5 side effects of eating too much Papaya
- Route to Christmas: Day 8 2024
.png)
